High-Tech, High-Touch
NCT07916818, Not applicable, Completed, Touro University, California
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | High-Tech, High-Touch | ClinicalTrials.gov |
| NCT number | NCT07916818 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 43 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Touro University, California | ClinicalTrials.gov |
| Conditions | Stress (Psychology), Resilience, Psychological, Anxiety, Depressive Symptoms, Well-being, Sleep Quality | ClinicalTrials.gov |
| Interventions | Wearable ring with continuous biometric monitoring, AI health coaching application, Osteopathic manipulative treatment (OMT) | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in resilience, measured by the Hardiness Resilience Gauge (HRG) Total Hardiness T-score | Baseline, Month 3, and Month 6 (end of study) | Standardized T-score derived from the Hardiness Resilience Gauge, reported in a standard score metric with a population mean of 100 and standard deviation of 15. Higher scores indicate greater psychological hardiness; the instrument's average range is 90 to 110. Total Hardiness is reported here; the Challenge, Control, and Commitment subscales are reported as secondary outcome measures. | ClinicalTrials.gov |
| Primary | Change in mood symptoms, measured by the Depression Anxiety Stress Scales-21 (DASS-21) | Baseline, Month 3, and Month 6 (end of study) | Three subscale scores (Depression, Anxiety, Stress). Each subscale is the sum of 7 items rated 0 to 3, multiplied by 2, giving a range of 0 to 42 per subscale. Higher scores indicate greater symptom severity. | ClinicalTrials.gov |
| Secondary | Change in nightly heart rate variability | Daily from baseline through month 6 | Mean overnight root mean square of successive differences (rMSSD), in milliseconds, recorded by the wearable ring. Higher values indicate greater parasympathetic activity. | ClinicalTrials.gov |
| Secondary | Change in device-derived daytime stress score | Daily from baseline through month 6 | Proprietary composite index of daytime physiological stress generated by the wearable device, reported daily. Higher values indicate greater stress. The metric begins reporting only after approximately two weeks of device wear. | ClinicalTrials.gov |
| Secondary | Change in sleep score | Daily from baseline through month 6 | Device-derived nightly composite sleep score ranging from 0 to 100. Higher values indicate better sleep. | ClinicalTrials.gov |
| Secondary | Change in readiness score | Daily from baseline through month 6 | Device-derived daily composite readiness score ranging from 0 to 100. Higher values indicate greater physiological readiness. | ClinicalTrials.gov |
| Secondary | Change in lowest nightly heart rate | Daily from baseline through month 6 | Minimum heart rate recorded overnight by the wearable device, in beats per minute. Higher values indicate greater physiological arousal. | ClinicalTrials.gov |
| Secondary | Change in resting heart rate contributor score | Daily from baseline through month 6 | Device-derived contributor score ranging from 0 to 100, in which higher values indicate a lower and more favorable resting heart rate. This field is a score rather than a rate in beats per minute, and is inversely scaled relative to heart rate. | ClinicalTrials.gov |
| Secondary | Participant-reported tool use and perceived effectiveness after study completion | 2 months and 7 months after study completion | Structured survey assessing continued use of each study tool (wearable ring, AI health coaching application), perceived effectiveness on ordinal rating scales, receipt of osteopathic manipulative treatment after study completion, and free-text description of participant experience. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)